<DOC>
	<DOCNO>NCT01694914</DOCNO>
	<brief_summary>At present , commercially available corneal organ culture medium contain foetal calf serum ( FCS ) sometimes compound extracted animal . These compound necessary corneal cell survival problematic theoretically risk anthropozoonosis transmission , especially new variant CJD variability FCS batch influence graft quality . Our laboratory research allow vitro ex vivo validation new medium free compound animal . We prove superiority conventional medium contain 2 % FCS endothelial cell survival storage time . The goal clinical trial ass superiority patient .</brief_summary>
	<brief_title>Comparative Study Two Corneal Graft Storage Media : New Animal Compound Free Medium Versus Reference Medium</brief_title>
	<detailed_description />
	<criteria>Male female patient 18 year age Clinically proven corneal disease Registered French National wait list ( GLAC ) Patient informed consent Patient need 8.25mm diameter perforate keratoplasty , either isolate combined lens surgery Low immune rejection risk ( &lt; 2 quadrant neovascularization , previous history herpetic keratitis graft rejection ) No previous history glaucoma elevate intra ocular pressure ( &gt; 22 mm Patient unlikely comply requirement protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Corneal Transplantation</keyword>
	<keyword>corneal organ culture medium</keyword>
	<keyword>free animal compound medium</keyword>
</DOC>